Research Article
Analysis of the Distribution and Antibiotic Resistance of Pathogens Causing Infections in Hospitals from 2017 to 2019
Table 14
Analysis of multiple drug resistance rates of CRE-KPN in 2017.
| | Drugs | Drug resistance rate (%) |
| CRE-KPN | Cotrimoxazole | 52.7 | | Fosfomycin | 60 | | Amikacin | 72.8 | | Tobramycin | 79 | | Gentamicin | 82.1 | | Nitrofurantoin | 96.3 | | Ciprofloxacin | 98.3 | | Levofloxacin | 98.3 | | Aztreonam | 98.6 | | Cefepime | 98.9 | | Piperacillin-tazobactam | 99.4 | | Ampicillin | 100 | | Cefoperazone-sulbactam | 100 | | Ampicillin-sulbactam | 100 | | Ceftazidime | 100 | | Ceftriaxone | 100 | | Ertapenem | 100 | | Imipenem | 100 |
|
|